SCHEMBL7812489

SCHEMBL7812489

Cc1cccnc1/C=C/C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.42
TNKS O95271 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
P4HTM Q9NXG6 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
FFAR1 O14842 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812493 1.00 HDAC3 (0.42) HDAC3TNKSHDAC4HDAC1HCAR2
SCHEMBL21942849 0.86 GLA (0.44) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL30585568 0.79 MAPT (0.42) KDM4EALDH1A1MAPTRAB9ANPC1
SCHEMBL9756900 0.79 NFE2L2 (0.53) HDAC3TNKSHDAC4HDAC1HCAR2
SCHEMBL9756902 0.79 NFE2L2 (0.53) HDAC3TNKSHDAC4HDAC1HCAR2
SCHEMBL3539217 0.79 RRM1 (0.43) HDAC3TNKSHDAC4HDAC1HCAR2
SCHEMBL3539220 0.79 RRM1 (0.43) HDAC3TNKSHDAC4HDAC1HCAR2
SCHEMBL14721797 0.78 NFE2L2 (0.55) KDM4EGAAALDH1A1NPC1ATM
SCHEMBL14721799 0.78 NFE2L2 (0.55) KDM4EGAAALDH1A1NPC1ATM
SCHEMBL15747042 0.77 CTH (0.44) KDM4EMAPTRAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242493-B1 PROSTAGLANDIN INHIBITORS; ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA & CO. (CA) 2001-06-05 US disclosed
EP-1071648-A2 CARBOXYLIC ACIDS AND ACYLSULFONAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT Merck Frosst Canada & Co. (CA) 2001-01-31 EP disclosed
WO-1999047497-A2 CARBOXYLIC ACIDS AND ACYLSULFONAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK FROSST CANADA & CO. (CA) 1999-09-23 WO disclosed
US-5039684-A Absorption when administered orally VALEAS S. P. A. (IT) 1991-08-13 US disclosed
EP-0384450-A1 Tetrazole amide derivatives of heterocyclic alkenyl acids and their use as antiallergic substances VALEAS S.p.A. INDUSTRIA CHIMICA E FARMACEUTICA (IT) 1990-08-29 EP disclosed